Provided herein are compositions and methods of treating liver cancer by novel anticancer agents.

Provided herein are compositions and methods of treating liver cancer by novel anticancer agents.

Use of 1-[(4R)-4-methylcyclohexen-1-yl]ethanone to impart a ylang-ylang note to a composition.

Use of 1-[(4R)-4-methylcyclohexen-1-yl]ethanone to impart a ylang-ylang note to a composition.

Disclosed are processes for making such cyclohexanone compositions from a mixture comprising phenol, cyclohexanone, and cyclohexylbenzene. Such cyclohexanone compositions comprise at least 99 wt % cyclohexanone, at most 0.15 wt % water, and at most 500 wppm combined of certain cyclohexanone impurities selected from the group consisting of: benzene, cyclohexene, pentanal, cyclopentanol, cyclohexanol, and phenol.

Disclosed are processes for making such cyclohexanone compositions from a mixture comprising phenol, cyclohexanone, and cyclohexylbenzene. Such cyclohexanone compositions comprise at least 99 wt % cyclohexanone, at most 0.15 wt % water, and at most 500 wppm combined of certain cyclohexanone impurities selected from the group consisting of: benzene, cyclohexene, pentanal, cyclopentanol, cyclohexanol, and phenol.

The present invention relates to the synthesis of intermediate compounds which can be used in the synthesis of mint lactone and related compounds, including 3,6-dimethylhexahydrobenzofuran-2-ones, isomers, and other derivatives.

The present invention relates to the synthesis of intermediate compounds which can be used in the synthesis of mint lactone and related compounds, including 3,6-dimethylhexahydrobenzofuran-2-ones, isomers, and other derivatives.

Use of 1-[(4R)-4-methylcyclohexen-1-yl]ethanone to impart a ylang-ylang note to a composition.

Use of 1-[(4R)-4-methylcyclohexen-1-yl]ethanone to impart a ylang-ylang note to a composition.